Tp-e Interval and QT Dispersion in Patients With Celiac Disease in ChildrenCEL-QTNCT07779993
Assessment of Tp-e Interval and QT Dispersion in Patients With Celiac Disease in Children
An observational study of Tp-e Interval and QT Dispersion in Patients With Celiac Disease in Children, run by Merna Fayez (Faiz) Shenoda at 1 site in Egypt.
Trial summary
This is a study at sohag university hospital aim to demonstrate if children with celiac disease have more sensitivity of their myocardium to arrhythmia compared to healthy children. Read more about this study
- Who is it for?
- Ages 0 to 18 years
- Conditions the study is for
- Tp-e Interval and QT Dispersion in Patients With Celiac Disease in Children
- How many people
- 30 participants
- Where
- 1 siteEgypt
- Study dates
- 1 Aug 2026to 1 Jul 2027
- Phase
- Observational
- Are there results?
- Not yet: the study is under way
Key requirements
Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.
- Ages 0 to 18 years
- All sexes
- No healthy volunteers
- Child, Adult
Study population: All children who confirmed diagnosed as celiac disease who visit sohag University Hospital at time of study under 18 years old and don't have any associated disease cross matched with same number of healthy children at the same age and not have any other problems at the duration of study.
Who may be able to join
- All children who confirmed diagnosed as celiac disease who visit sohag University Hospital
Who cannot join
- cardiac disease.
Trial locations and contacts
1 site in 1 country. Contact the study team or a site near you to ask about taking part.
Egypt1 site
Sohag University Hospital
Sohag
Merna fayez shenouda, 01220120206, merna.faiz@med.edu.sohag
About this study
Official title: Assessment of Tp-e Interval and QT Dispersion in Patients With Celiac Disease in Children at Sohag University Hospital
This is a study at sohag university hospital aim to demonstrate if children with celiac disease have more sensitivity of their myocardium to arrhythmia compared to healthy children.
Read the detailed description
This study is a case control aims to :
- Assess Tp-e interval, Tp e/QTc ratio , Tp-e/QT ratio and QT dispersion in patients with celiac disease attending Sohag University Hospital
- Compare Tp e interval, Tp e/QT ratio ,Tp e/QTc ratio and and QT dispersion between children with celiac disease and healthy controls.
- With there parameters demonstrate if children with celiac disease have more sensitivity of their myocardium to arrhythmia compared to healthy children.
- Being tested
- No intervention (observational study)
- Keywords
- Celiac Disease, Tp-e Interval and QT dispersion
- Medical subject headings
- Celiac Disease
What participants receive
What participants receive. In a randomised study each person is assigned to one group by chance.
No intervention (observational study)Other
the study don't need intervention.
| Study group | Role | What they receive |
|---|---|---|
| children with celiac disease | children from birth to 18 years old diagnosed with celiac disease visit sohag university hospital Receives: Other: No intervention (observational study) |
What is being measured
The primary outcome is the main question the study is designed to answer.
Assessment of Tp-e Interval
Assessment of Tp-e Interval in children diagnosed with celiac disease and compare it with healthy children
Measured: 1 year
Secondary outcomes (1)
Assessment of QT dispersion
Assessment of QT dispersion in children diagnosed with celiac disease and compare it with healthy children
Measured: 1 year
Timeline
From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.
- First posted21 Aug 2026
- Study start1 Aug 2026 (estimated)
- Primary completion1 Jun 2027 (estimated)
- Study completion1 Jul 2027 (estimated)
Resources
- Official record on ClinicalTrials.govThe registry entry this page is built from, with its full change history.
- Other trials for Tp-e Interval and QT Dispersion in Patients With Celiac Disease in ChildrenStudies of the same condition, open and under way.
- What the trial phases meanHow a treatment moves from first tests in people to approval.
More details
For doctors and researchers: how the study is designed, who runs it, and its registry IDs.
Study design
- Study type
- Observational
- Observational model
- Case-control
- Time perspective
- Prospective
- Enrolment
- 30 participants (estimated)
Sponsor and investigators
- Lead sponsor
- Merna Fayez (Faiz) Shenoda
- Sponsor type
- University, hospital or other
- Responsible party
- Sponsor-investigator, Merna Fayez (Faiz) Shenoda, Sohag University
IDs, dates and publications
- ClinicalTrials.gov ID
- NCT07779993
- Sponsor's protocol ID
- soh-Med-26-7-20Ms
- Acronym
- CEL-QT
- Status last verified
- Jul 2026
- First submitted
- 14 Aug 2026
- Last updated
- 21 Aug 2026
- Results posted
- No
- Data monitoring committee
- No
- FDA-regulated drug
- No
- FDA-regulated device
- No
- Individual data sharing
- No: individuals participant data will not be shared due to privacy protection policies at Sohag university Hospital
Study at a glance
From the registry record, last updated by the sponsor on 21 Aug 2026. Recruitment status is as the sponsor reported it: confirm with the study team.
- Official title
- Assessment of Tp-e Interval and QT Dispersion in Patients With Celiac Disease in Children at Sohag University Hospital
- ClinicalTrials.gov ID
- NCT07779993
- Acronym / sponsor ID
- CEL-QT / soh-Med-26-7-20Ms
- Keywords
- Celiac Disease, Tp-e Interval and QT dispersion
- Study type
- Observational
- Recruitment status
- Not yet recruiting
- Enrolment
- 30 participants (estimated)
- Lead sponsor
- Merna Fayez (Faiz) ShenodaUniversity, hospital or other
- Study start
- 1 Aug 2026 (estimated)
- Primary completion
- 1 Jun 2027 (estimated)
- Study completion
- 1 Jul 2027 (estimated)
- First posted
- 21 Aug 2026 (actual)
- Results
- Not posted in the source record
Clinical summary
The research question as the sponsor registered it. This describes what the study plans to test, not what it found.
This is a study at sohag university hospital aim to demonstrate if children with celiac disease have more sensitivity of their myocardium to arrhythmia compared to healthy children.
Detailed description
This study is a case control aims to :
- Assess Tp-e interval, Tp e/QTc ratio , Tp-e/QT ratio and QT dispersion in patients with celiac disease attending Sohag University Hospital
- Compare Tp e interval, Tp e/QT ratio ,Tp e/QTc ratio and and QT dispersion between children with celiac disease and healthy controls.
- With there parameters demonstrate if children with celiac disease have more sensitivity of their myocardium to arrhythmia compared to healthy children.
Study design
- Observational model
- Case-control
- Time perspective
- Prospective
- Number of arms
- 1
| Arm | Type | Receives |
|---|---|---|
| children with celiac disease | – | Other: No intervention (observational study)children from birth to 18 years old diagnosed with celiac disease visit sohag university hospital |
Who may qualify
- Ages
- 0 to 18 years
- Sex
- All
- Healthy volunteers
- Not accepted
- Age groups
- Child, Adult
- Study population
- All children who confirmed diagnosed as celiac disease who visit sohag University Hospital at time of study under 18 years old and don't have any associated disease cross matched with same number of healthy children at the same age and not have any other problems at the duration of study.
Key inclusion criteria (1 listed)
- All children who confirmed diagnosed as celiac disease who visit sohag University Hospital
Key exclusion criteria (1 listed)
- cardiac disease.
Eligibility is decided by the study team after screening; this overview does not establish that a patient qualifies. Full inclusion and exclusion criteria.
Interventions
| Intervention | Type | Arms |
|---|---|---|
| No intervention (observational study)the study don't need intervention. | Other | children with celiac disease |
Primary outcome
Assessment of Tp-e Interval
Time frame: 1 year
Assessment of Tp-e Interval in children diagnosed with celiac disease and compare it with healthy children
1 secondary outcome
Assessment of QT dispersion
Time frame: 1 year
Results and safety
This study is still under way. Results are not available in the source record yet.
Research links
- Official record on ClinicalTrials.govLast updated by the sponsor 21 Aug 2026.
- Related InfoLink provided by the sponsor.
- Individual participant dataSharing planned: No. individuals participant data will not be shared due to privacy protection policies at Sohag university Hospital
Referral and contact
AzTrials does not enrol participants or take referrals. Contact the study team or a site listed below; they decide who can take part.
1 site in 1 country: see every site and its status.
Questions about this trial
What is this clinical trial studying?
An observational study of Tp-e Interval and QT Dispersion in Patients With Celiac Disease in Children, run by Merna Fayez (Faiz) Shenoda at 1 site in Egypt.
The full registered description is in the About this study section and the official record.
Who may be eligible to take part?
The sponsor lists 1 inclusion and 1 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.
Is this clinical trial currently recruiting?
The record says: opening soon, as of the sponsor's last update on 21 Aug 2026. Status can change between updates, so confirm with the study contact before making plans.
Where is the study taking place?
The record lists 1 site in Egypt. Whether a site is taking part right now should be confirmed with that site. See every site.
What are the possible benefits and risks?
They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.
Are results available for this study?
This study is still under way. Results are not available in the source record yet.
How can a doctor refer a patient or contact the research team?
Contact Merna Fayez Shenouda (01220120206, merna.faiz@med.sohag.edu.eg), or a site near the patient. AzTrials does not enrol participants or take referrals.
What does the primary outcome measure?
Assessment of Tp-e Interval (time frame: 1 year). It is what the study was designed to measure, not a finding.
Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?
No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.
How often is this information updated?
AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 21 Aug 2026.